Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
  1. 4 Grant or award Director acquired 10,200 shares (grant or award)
  2. 4 Grant or award Director acquired 10,200 shares (grant or award)
  3. 4 Grant or award Director acquired 10,200 shares (grant or award)
  4. 4 Grant or award Director acquired 10,200 shares (grant or award)
  5. 4 Grant or award Director acquired 10,200 shares (grant or award)
  6. 4 Grant or award Director acquired 10,200 shares (grant or award)
  7. 4 Open-market sale Director sold 21,267 shares at $3.61 ($76,774)
  8. 4 Open-market sale Chief R&D Officer sold 73,716 shares at $4.65 ($342,779)
  9. 4 Open-market sale Chief R&D Officer sold 10,560 shares at $4.76 ($50,266)
  10. 4 Open-market sale SVP & General Counsel sold 3,189 shares at $4.76 ($15,180)
  11. 4 Open-market sale SVP & Chief Accounting Officer sold 2,006 shares at $4.76 ($9,549)
  12. 4 Open-market sale President & CEO sold 13,759 shares at $4.76 ($65,493)
  13. 4 Open-market sale Chief R&D Officer sold 21,673 shares at $3.95 ($85,608)
  14. 4 Open-market sale SVP & General Counsel sold 3,136 shares at $3.95 ($12,387)
  15. 4 Open-market sale SVP & Chief Accounting Officer sold 5,841 shares at $3.95 ($23,072)
  16. 4 Open-market sale President & CEO sold 36,529 shares at $3.95 ($144,290)
  17. 4 Open-market sale SVP & Chief Commercial Officer sold 4,592 shares at $3.95 ($18,138)
  18. 4 Open-market sale SVP, COO & CFO sold 17,448 shares at $3.95 ($68,920)
  19. 4 Open-market sale Chief R&D Officer sold 10,912 shares at $10.95 ($119,486)
  20. 4 Open-market sale SVP & General Counsel sold 3,661 shares at $10.95 ($40,088)

Page 6 of 49 · 968 filings